Polio: Measuring the protection that matters most

Journal of Infectious Diseases

Volumn 200, Issue 5, 2009, Pages 673-675

  Fine, Paul E M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ANTIBODY TITER; DISEASE TRANSMISSION; HEALTH PROGRAM; HUMAN; INDIA; INFECTION PREVENTION; MUCOSAL IMMUNITY; NONHUMAN; NOTE; POLIOMYELITIS; PRIORITY JOURNAL; VACCINATION; VIRUS EXCRETION; VIRUS IMMUNITY; WORLD HEALTH ORGANIZATION; AFGHANISTAN; IMMUNOLOGY; INFANT; NEWBORN; NIGERIA; PAKISTAN; PRESCHOOL CHILD; VIRUS SHEDDING;

AFGHANISTAN; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INDIA; INFANT; INFANT, NEWBORN; NIGERIA; PAKISTAN; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; VIRUS SHEDDING;

EID: 70349314775     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605331     Document Type: Note

References (8)

1. Grassly NC, Jafari H, Bahl S, et al. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India. J Infect Dis 2009;200:794-801 (in this issue).
2. Ghendon YZ, Sanakoyeva II. Comparison of the resistance of the intestinal tract to poliomyelitis virus (Sabin's strains) in persons after naturally and experimentally acquired immunity. Acta Virol 1961; 5:265-273
3. Onerato IM, Modlin JF, McBean AM, Thorns ML, Losonsky GA, Bernier RH. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991; 163:1-6.
4. 4. Laassri M, Lottenbach K, Belshe R, et al. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. J Infect Dis 2005; 192:2092-2098 (Pubitemid 41779206)
5. 5. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case control study. Lancet 2007;369:1356-1362 (Pubitemid 46613904)
6. John TJ. The golden jubilee of vaccination against poliomyelitis. Indian J Med Res 2004; 119:1-17.
7. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13:926-939
8. 8. Posey DL, Linkins RW, Oliviera MJC, Monteiro D, Patriarca PA. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997; 175(Suppl 1):S258-63. (Pubitemid 27053519)